Dodda Bhargavi, Srihari Konduri, Jyothi Prashanth, Sowjanya Pulipati, K. K. Praneeth, Malladi Sireesha and Koya Prabhakara Rao
RSC Adv., 2023,13, 13540-13546
Abstract
We identified twenty-two new sacubitril derivatives (5a–v) as lead compounds for various biologically active targets.
Rajendra Prasad Pakhariya, Ayushi Bhatnagar and Gangotri Pemawat
RSC Adv., 2025,15, 3646-3663
From themed collection:
2025 Reviews in RSC Advances
Abstract
Graphical representation of quinoline-based molecular frameworks: synthesis and structural diversity.
Yogesh Mahadu Khetmalis, Singarapalle Shobha, Adinarayana Nandikolla, Ala Chandu, Sankaranarayanan Murugesan, Muthyala Murali Krishna Kumar and Kondapalli Venkata Gowri Chandra Sekhar
RSC Adv., 2024,14, 22676-22689
Abstract
Twenty-eight compounds, viz., 1,8-naphthyridine-3-carbonitrile (ANC and ANA) derivatives, were designed and synthesized through a molecular hybridization approach. The designed compounds were evaluated for anti-TB activity against Mtb H37Rv strain.
Sauvik Samanta, Sumit Kumar, Eswar K. Aratikatla, Sandeep R. Ghorpade and Vinayak Singh
RSC Med. Chem., 2023,14, 644-657
Abstract
Here, we critically review anti-TB compounds of the imidazo[1,2-a]pyridine class by discussing their development based on the structure–activity relationship, mode-of-action, and various scaffold hopping strategies over the last decade.
Adinarayana Nandikolla, Yogesh Mahadu Khetmalis, Boddupalli Venkata Siva Kumar, Ala Chandu, Banoth Karan Kumar, Gauri Shetye, Rui Ma, Sankaranarayanan Murugesan, Scott G. Franzblau and Kondapalli Venkata Gowri Chandra Sekhar
RSC Med. Chem., 2023,14, 1549-1561
Abstract
Amongst the Phenanthridine amides and triazoles reported in this work, PA-01 and PT-09 emerged as the most active anti-tubercular agents against Mtb H37Rv strain in MABA and LORA assays.